Everolimus-induced nephrotic syndrome precipitated by interaction with voriconazole in a patient with Hodgkin's lymphoma

Lymphoma

Hodgkin’s Lymphoma after Autologous Stem-Cell Transplantation: Effective Consolidation with Brentuximab Vedotin

healthbook Times Oncology Hematology

Schmidt A

doi: 10.36000/hbT.OH.2020.06.025

RECOMMENDED

Skin Cancer

Cytokine Release Syndrome During Sequential Treatment With Immune Checkpoint Inhibitors and Kinase Inhibitors for Metastatic Melanoma

J Immunother.

Dimitriou F, Matter AV, Mangana J, Urosevic-Maiwald M, Micaletto S, Braun RP, French LE, Dummer R

doi: 10.1097/CJI.

Genitourinary CancerLymphoma

Incidental finding of non-Hodgkin's lymphoma in a patient affected by castration-sensitive prostate cancer: A case report

Medicine (Baltimore).

Pirozzi A, Cartenì G, Scagliarini S, Fusco M, Riccardi F

doi: 10.1097/MD.

Lymphoma

Successful treatment with low-dose nivolumab in refractory Hodgkin lymphoma after allogeneic stem cell transplantation

Int J Hematol.

Onizuka M, Kojima M, Matsui K, Machida S, Toyosaki M, Aoyama Y, Kawai H, Amaki J, Hara R, Ichiki A, Ogawa Y, Kawada H, Nakamura N, Ando K

doi: 10.1007/

Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial.

Lancet Oncol.

Armstrong AJ, Halabi S, Eisen T, Broderick S, Stadler WM, Jones RJ, Garcia JA, Vaishampayan UN, Picus J, MD, Hawkins RE, Hainsworth JD, Kollmannsberger CK, MD, Logan TF, Puzanov I, Pickering LM, Ryan CW, Protheroe A, Lusk CM, Oberg S, George DJ

doi: 10.1016/

Lymphoma

Rationale for targeting tumor cells in their microenvironment for mantle cell lymphoma treatment

Leuk Lymphoma.

Papin A, Le Gouill S, Chiron D

doi: 10.1080/

Lymphoma

Primary Cutaneous Anaplastic Lymphoma Kinase-Positive Large B-Cell Lymphoma

Am J Dermatopathol.

Kempf W, Torricelli R, Zettl A, Zimmermann AK, Berisha A, Ghielmini M

doi: 10.1097/DAD.

Lymphoma

Cerebellar large B-cell lymphoma: a case report

doi: 10.1186/s13256-018-1880-z.

Non-Malignant Blood Disorders

Maintenance rituximab for relapsing thrombotic thrombocytopenic purpura: a case report

Transfusion.

Saleem R, Rogers ZR, Neunert C, George JN

doi: 10.1111/trf.15093.

Related content

Hodgkin’s Lymphoma after Autologous Stem-Cell Transplantation: Effective Consolidation with Brentuximab Vedotin

Cytokine Release Syndrome During Sequential Treatment With Immune Checkpoint Inhibitors and Kinase Inhibitors for Metastatic Melanoma

Incidental finding of non-Hodgkin's lymphoma in a patient affected by castration-sensitive prostate cancer: A case report

Successful treatment with low-dose nivolumab in refractory Hodgkin lymphoma after allogeneic stem cell transplantation

Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial.

Rationale for targeting tumor cells in their microenvironment for mantle cell lymphoma treatment

Primary Cutaneous Anaplastic Lymphoma Kinase-Positive Large B-Cell Lymphoma

Cerebellar large B-cell lymphoma: a case report

Maintenance rituximab for relapsing thrombotic thrombocytopenic purpura: a case report